Security Reports > BioLineRx

Data Breaches, Cyber Attacks and Security Report  ᛫  Biotech & Pharmaceuticals
Last updated August 3, 2020

BioLineRx Security Rating

/ 950

UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely BioLineRx is implementing good security practices.

Company Information


About BioLineRx

BioLineRx, or BioLine, is a publicly traded drug development company that seeks to discover compounds for disease treatment and develop them into commercializable drugs. Headquartered in Israel, its shares are traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange.

Data Breaches and Security News

Security Report for BioLineRx

Want a security rating for your organization?

This report shows a preliminary security rating for BioLineRx. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.

Get a deeper scan

Related posts

Read more about the latest issues in cybersecurity

More security reports

Compare BioLineRx's security performance with other companies